Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of CTT Pharmaceutical Holdings, Inc.
No Price
Closing Price OTC 28.04.2026:
0,07 USD
28.04.2026 20:00
Current Prices from CTT Pharmaceutical Holdings, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
CTTH
USD
28.04.2026 20:00
0,07 USD
-0,005 USD
-5,70 %
Company Profile for CTT Pharmaceutical Holdings, Inc. Share
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. The company is based in Ottawa, Canada.
